SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.050+1.0%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stephen D. French who wrote (7)7/14/1997 10:28:00 PM
From: Skywatcher   of 645
 
Yes, Steven, this result is extremely impressive. I really can't say enough about the potential for this anti'flu vaccine being a profit maker. Just look at the results...very strong...and the nasal application makes this just that much more appealing and profitable.
They have an excellent relationship with a good vaccine manufacturer and have not signed on to a final agreement with them until the results were in . This is good thinking and could mean subsantially more profits for them in the not so distant future. However one must take into consideration the need for more cash from some source since it seems that vaccines are indeed pricey and difficult to make on a real consistant basis.
chris
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext